ArticleTranslational oncology2025

CRISPR/Cas9-mediated PD-1 attenuation enhances tumor infiltrating lymphocyte-based adoptive cellular therapy in humanized-PDX model of hepatocellular carcinoma.

Wu Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.